Acute revascularization in ST-segment-elevation myocardial infarction
Language English Country United States Media print
Document type Journal Article, Review
- MeSH
- Anticoagulants therapeutic use MeSH
- Myocardial Infarction therapy MeSH
- Platelet Aggregation Inhibitors therapeutic use MeSH
- Humans MeSH
- Myocardial Revascularization * methods MeSH
- Risk Factors MeSH
- Stents * MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
- Names of Substances
- Anticoagulants MeSH
- Platelet Aggregation Inhibitors MeSH
We briefly and comprehensively present some of the novel findings in the field of revascularization therapy and management of ST-segment-elevation myocardial infarction (STEMI). We highlight the latest evidence-based advancements in the pharmacological and mechanical treatment of patients who presented with STEMI. Since the last updates to the international guidelines (American College of Cardiology/American Heart Association and the European Society of Cardiology) were published in 2011 and 2012, there have been changes and several important studies have presented their final outcomes. We also highlight some controversial approaches as part of the current debates in the cardiology community. In addition, we share our recent experience in the field of biodegradable scaffold stents as a treatment strategy in STEMI.
See more in PubMed
Lancet. 2009 Feb 28;373(9665):723-31 PubMed
J Am Coll Cardiol. 2013 Feb 5;61(5):536-44 PubMed
Eur Heart J. 2012 Oct;33(20):2569-619 PubMed
Am J Cardiol. 2011 Dec 15;108(12):1697-703 PubMed
Circulation. 1998 Jun 30;97(25):2502-5 PubMed
J Am Coll Cardiol. 2013 Aug 6;62(6):496-504 PubMed
JACC Cardiovasc Interv. 2010 Jun;3(6):571-83 PubMed
N Engl J Med. 2013 Sep 19;369(12):1115-23 PubMed
Clin Res Cardiol. 2014 Feb;103(2):141-8 PubMed
J Interv Cardiol. 2013 Oct;26(5):515-23 PubMed
Circ Cardiovasc Qual Outcomes. 2013 Jul;6(4):400-8 PubMed
Lancet. 2003 Jan 4;361(9351):13-20 PubMed
Hamostaseologie. 2014;34(1):47-53 PubMed
Int J Cardiol. 2013 Oct 3;168(3):2579-87 PubMed
Catheter Cardiovasc Interv. 2014 Nov 15;84(6):955-62 PubMed
EuroIntervention. 2009 Aug;5(3):299, 301-309 PubMed
Eur Heart J. 2011 Feb;32(4):396-403 PubMed
Lancet. 2012 Oct 27;380(9852):1482-90 PubMed
Circulation. 2010 Nov 23;122(21):2131-41 PubMed
JAMA. 2012 Sep 12;308(10):998-1006 PubMed
J Am Coll Cardiol. 2013 Jan 29;61(4):e78-e140 PubMed
JACC Cardiovasc Interv. 2012 Sep;5(9):919-26 PubMed
Lancet. 2012 Mar 10;379(9819):923-931 PubMed
N Engl J Med. 2010 Jun 10;362(23):2155-65 PubMed
Eur Heart J. 2010 Jul;31(14):1701-7 PubMed
N Engl J Med. 2013 Apr 4;368(14):1303-13 PubMed
Am J Cardiol. 2000 Jun 1;85(11):1292-6 PubMed
BMJ. 2013 Nov 08;347:f6625 PubMed
Am J Cardiol. 2002 Jan 15;89(2):115-20 PubMed
Vasc Health Risk Manag. 2012;8:115-23 PubMed
Eur Heart J. 2014 Mar;35(12):787-94 PubMed
N Engl J Med. 2013 Apr 11;368(15):1379-87 PubMed
Int Heart J. 2006 Jan;47(1):47-57 PubMed
Am Heart J. 2013 Feb;165(2):241-50.e4 PubMed
J Am Coll Cardiol. 2002 Jan 2;39(1):15-21 PubMed
Circulation. 2013 Jul 23;128(4):352-9 PubMed
Eur Heart J. 2010 Apr;31(8):943-57 PubMed
Neth Heart J. 2010 Aug;18(7-8):348-54 PubMed
